This Week in Addiction Medicine from ASAM
Avsnitt

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

This Week in Addiction Medicine from ASAM
Dela

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

BMJ Open

This retrospective cohort study using target trial emulation evaluated the association between use of newer glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide, tirzepatide) and alcohol-related hospitalizations among adults with alcohol use disorder (AUD) and type 2 diabetes (T2D) or obesity. The authors found that among adults with AUD and T2D or obesity, initiation of newer GLP-1 RAs was associated with a lower observed risk of alcohol-related hospitalization. 

 

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör American Society of Addiction Medicine. Innehållet i podden är skapat av American Society of Addiction Medicine och inte av, eller tillsammans med, Poddtoppen.